"Life Benefits Service, Ltd'
Welcome,         Profile    Billing    Logout  
 1 Trial 
3 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lioznov, Dmitry
NCT04526990: Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above

Recruiting
3
40000
RoW
Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector), Placebo
CanSino Biologics Inc., Beijing Institute of Biotechnology
COVID-19
12/21
01/22
NCT04684446: Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime-Boost Regimen for the Prevention of COVID-19

Recruiting
1/2
100
RoW
AZD1222, rAd26-S, Sputnik V
R-Pharm, AstraZeneca, Russian Direct Investment Fund, The Gamaleya National Center of Epidemiology & Microbiology
COVID-19
04/22
04/22
Olga, Rybina
NCT04526990: Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above

Recruiting
3
40000
RoW
Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector), Placebo
CanSino Biologics Inc., Beijing Institute of Biotechnology
COVID-19
12/21
01/22

Download Options